Sponsor

MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan

Clinical research sponsor

Published trials6

Recruiting shown0

Roles1

SourceClinicalTrials.gov

Clinical trials

6 shown

Tolerability and PK of Submicron Budesonide in Children 4 to 11 Years Old With Mild-To-Moderate Stable AsthmaNCT00995904 · collaborator · 2009-09-01

COMPLETED

A Study of 2 Doses of MAP0010 in Asthmatic ChildrenNCT00697697 · collaborator · 2008-04-01

TERMINATED

A Study of 2 Doses of MAP0010 and Placebo in Asthmatic ChildrenNCT00569192 · collaborator · 2007-12-01

COMPLETED

A Study of 2 Doses of MAP0010 in Adult AsthmaticsNCT00554970 · collaborator · 2007-11-01

COMPLETED

Study of MAP0010 in Asthmatic Children and AdolescentsNCT00697801 · collaborator · 2006-07-01

COMPLETED

Safety and Blood Level Study of Unit Dose BudesonideNCT00627679 · collaborator · 2005-12-01

COMPLETED

Sponsor roles

collaborator6

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.